Levocetirizine Dihydrochloride Tablet
Product Images NDC 51655-564

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 51655-564). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levocetirizine Structure)

Chemical Structure (Levocetirizine Structure)
Chemical structure of levocetirizine dihydrochloride showing its molecular arrangement, including aromatic rings, a piperazine ring, and hydrochloride salts indicated by .2HCl.*
FDA Label Image

Label (51655 564 52 Rev B 02 22 Nhc)

Label (51655 564 52   Rev B 02 22 Nhc)
Label for Levocetirizine Dihydrochloride Tablets USP 5 mg, oral tablets supplied in a package of 30 tablets. The label includes storage instructions, prescription status (Rx only), labeler as Northwind Health Company, LLC, and the NDC number 51655-564-52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.